Cancer drug could treat early|stage Alzheimer's disease

Cancer drug could treat early-stage Alzheimer's disease, study shows

A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer's, ...

Alzheimer's: Novel cancer drug restores cognition, memory loss in ...

Researchers identified an enzyme that regulates glucose metabolism in the brain and discovered that a cancer drug may help treat early-stage Alzheimer's ...

Cancer drug could treat early-stage Alzheimer's disease, study shows

A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer's, ...

Alzheimer's Mice Have Memory and Brain Function "Rescued" by ...

The results of research in mice suggest that a type of drug developed for treating cancer may hold promise as a new treatment for ...

Three promising drugs for treating Alzheimer's disease bring fresh ...

This 18-month trial will focus on individuals with early-stage Alzheimer's disease and will test whether buntanetap can help slow down the progression of ...

Repurposed cancer treatments could be potential Alzheimer's drugs

Using cell culture models, the investigators then found that two compounds — Dasatinib, an already FDA-approved treatment for chronic myeloid ...

New cancer drugs might also help treat Alzheimer's - UPI.com

A new type of cancer drug might help treat brain diseases like Alzheimer's, mouse studies suggest.

Advances in cancer neuroscience and drug discovery could benefit ...

Unparalleled drug discovery and development expertise · Alzheimer's disease and age-related diseases could affect future cancer research and care.

New hope for Alzheimer's patients? Cancer drug shows 'high potential'

A type of drug being developed to combat cancer could be repurposed to treat the early stages of neurodegenerative diseases such as ...

Cancer drug may treat early-stage Alzheimer's disease, study finds

A drug made to treat cancer could be a viable treatment for neurodegenerative diseases such as Alzheimer's disease, a new study finds.

What is donanemab? | Alzheimer's Society

It joins lecanemab (marketed as Leqembi) as the second drug to be licensed as a treatment for early-stage Alzheimer's disease in the UK.

Alzheimer's treatments: What's on the horizon? - Mayo Clinic

A medicine initially developed as a possible cancer treatment — saracatinib — is now being tested in Alzheimer's disease. In mice, saracatinib turned off a ...

Repurposed experimental cancer drug restores brain function in ...

Scientists have found that a compound originally developed as a cancer therapy potentially could be used to treat Alzheimer's disease.

Cancer drug could treat early-stage Alzheimer's disease, study shows

A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer's, according to a ...

Researchers call for a major rethink of how Alzheimer's treatments ...

In January 2023, the US Food and Drug Administration (FDA) approved lecanemab — an antibody medication that decreases β-amyloid protein build-up ...

Cancer chemotherapy drug reverses Alzheimer's symptoms in mice

The drug, Axitinib, inhibits the growth of new blood vessels in the brain—a feature shared by both cancer tumours and Alzheimer's disease, but ...

Leqembi: What Physicians Need to Know About the New ...

FDA fully approves Leqembi® for early-stage Alzheimer's disease treatment, available at Northwestern Medicine's Mesulam Center, learn more about this new ...

Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the ...

"Kisunla demonstrated very meaningful results for people with early symptomatic Alzheimer's disease, who urgently need effective treatment ...

What to know about the new Alzheimer's drug Leqembi

The FDA has granted full approval to Leqembi (lecanemab) for patients in the early stages of Alzheimer's disease. WashU Medicine will offer the drug to those ...

New Drug Offers Hope for Early-Stage Alzheimer's Disease

Leqembi is the first U.S. FDA-approved medication to alter how Alzheimer's disease physically affects the brain rather than just treat its ...